The 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, took place on 3-5 November in Glasgow, UK. Watch our expert interviews from the largest cancer research conference in the UK.

NCRI 2019

NCRI 2019

The 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, took place on 3-5 November in Glasgow, UK. Watch our expert interviews from the largest cancer research conference in the UK.

Targeted screening and risk stratification of prostate cancer – updates from the IMPACT study 2:43
Targeted screening and risk stratification of prostate cancer – updates from the IMPACT study
Rosalind Eeles
Producing patient-specific tumor-reactive T-cells 3:05
Producing patient-specific tumor-reactive T-cells
Chiara Cattaneo
Is age a barrier for chemotherapy? 5:04
Is age a barrier for chemotherapy?
Nicolò Battisti
Challenges with chemotherapy in older patients 1:56
Challenges with chemotherapy in older patients
Nicolò Battisti
Radiation on tumor antigenicity and adjuvanticity 3:56
Radiation on tumor antigenicity and adjuvanticity
Sandra Demaria
The UK approach to proton beam therapy clinical trials 4:30
The UK approach to proton beam therapy clinical trials
David Sebag-Montefiore
Other factors to consider with radiation effects on tumor antigenicity and adjuvanticity 2:15
Other factors to consider with radiation effects on tumor antigenicity and adjuvanticity
Sandra Demaria
Managing patients’ fear of cancer progression 3:34
Managing patients’ fear of cancer progression
Phyllis Butow
Enthusiasm bias with novel robotic technology for surgery 2:53
Enthusiasm bias with novel robotic technology for surgery
Peter McCulloch
Precision medicine in gastrointestinal cancers: promise and pitfalls 3:09
Precision medicine in gastrointestinal cancers: promise and pitfalls
Russell Petty
Epigenetics and epitranscriptomics: from knowledge to applications 3:21
Epigenetics and epitranscriptomics: from knowledge to applications
Manel Esteller
The future of proton beam therapy: assistance from European clinical trials 1:37
The future of proton beam therapy: assistance from European clinical trials
Cai Grau
Robotic technology: hype or game changers? 2:36
Robotic technology: hype or game changers?
Peter McCulloch
Colorectal cancer subtyping using a histology based approach 4:31
Colorectal cancer subtyping using a histology based approach
Joanne Edwards
HER-2 conversion: a phenomenon in trastuzumab resistance 2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
Immunotherapy – from bench to bedside 2:48
Immunotherapy – from bench to bedside
Kevin Litchfield
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals